-
(ANGX.N) fell -12.71% with weak technical signals and a 3.77 diagnostic score, indicating bearish market pressure.
- U.S. vaccine policy shifts and China's 49.5 PMI contraction highlight risks to healthcare/biotech sectors, indirectly affecting Angel's demand.
- One analyst rates Angel as "Strong Buy" (100% success rate), but big-money investors show 48.52% outflow versus retail optimism (51.31% inflow).
- Technical analysis reveals 1 bearish pattern (Long Lower Shadow) vs 0 bullish signals, with WR Oversold showing limited recent relevance.
- Market divergence between analyst optimism and price decline suggests caution, with no clear trend amid mixed institutional/retail flows.
Comments
No comments yet